Peter William Hunt MD

ID / HIV-AIDS at SFGH / UCSF

995 Potrero AveSfgh Building 80, Ward 84San Francisco, CA 94110
Phone+1 415-476-4082
Fax+1 415-476-6953

Dr. Hunt is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hunt's full profile Already have an account?

Education & Training

University of California (San Francisco)Fellowship, Infectious Disease, 2003 - 2006
University of California (San Francisco)Residency, Internal Medicine, 1998 - 2001
Yale School of MedicineClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2000 - 2027
American Board of Internal Medicine Infectious Disease

Clinical Trials

Valganciclovir to Reduce T Cell Activation in HIV Infection
COMPLETED
PHASE4
Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
COMPLETED
PHASE4

Publications & Presentations

PubMed

8 citations
Mpox in People With HIV: Predictors of Diagnosis, Outcomes, and Vaccine Effectiveness in a Multisite Cohort.
Michalina Montaño, Adrienne E Shapiro, Bridget M Whitney, Laura Bamford, Greer Burkholder
Clinical Infectious Diseases. 2026-02-09
Moderate to Severe Impairment of Dland Iso↓DlAre Associated with All-Cause Mortality in People with Human Immunodeficiency Virus.
Michelle H Zhang, Jessica Fitzpatrick, Jake Branchini, Katerina L Byanova, Rebecca Abelman
Annals of the American Thoracic Society. 2025-10-01
3 citations
Microbial translocation and gut damage is associated with hepatic fibrosis but not steatosis in women with and without HIV.
Maria J Duarte, Phyllis C Tien, Ani Kardashian, Yifei Ma, Peter Hunt
AIDS. 2025-07-15

Journal Articles

Gut and Blood Differ in Constitutive Blocks to HIV Transcription, Suggesting Tissue-Specific Differences in the Mechanisms That Govern HIV Latency
Steven A Yukl, Ma Somsouk, Steven G Deeks, Sulggi Lee, Hiroyu Hatano, Peter W Hunt, Joseph K Wong, PLoS One
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity
Peter W Hunt, David R Bangsberg, mBio
Lower Pretreatment Gut Integrity Is Independently Associated with Fat Gain on Antiretroviral Therapy
Judith S Currier, Peter W Hunt, Clinical Infectious Diseases

Press Mentions

Is the Therapeutic Potential of Hallucinogens Risky and Overhyped?August 20th, 2023

Grant Support

Stimulant and Polysubstance use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)NORTHERN CALIFORNIA INSTITUTE/RES/EDU2025–2030
Stimulant and Polysubstance use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)NORTHERN CALIFORNIA INSTITUTE/RES/EDU2025–2030
Impact of Asymptomatic CMV on Cardiovascular Event Risk in Treated HIVUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2025–2029
Understanding and targeting the HIV-expressing reservoir to reduce immune activationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029
Assessing the Interrelationship Between Adipose Tissue Thermogenesis and Fibrosis in the Metabolic Health of People Living with HIVUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2029